Ventripoint Diagnostics Tech To Be Used To Study Atrial Dysfunction In Children
Ventripoint Diagnostics (CSE: VPT) this morning announced the beginning of a new clinical study being conducted by the Department of
Read moreVentripoint Diagnostics (CSE: VPT) this morning announced the beginning of a new clinical study being conducted by the Department of
Read moreVentripoint Diagnostics (TSXV: VPT) this morning provided an update on its sales and marketing activities within China, where the firm
Read moreVentripoint Diagnostics (TSXV: VPT) is starting today off refreshed, after having cleaned up its a balance sheet. The company this
Read moreToday on the Daily Dive is that of George Adams, CEO of Ventripoint Diagnostics (TSXV: VPT). Adams joins host Cassandra
Read moreVentripoint Diagnostics (TSXV: VPT) has been one of the largest movers of the week, with over 19.3 million shares trading
Read moreVentripoint Diagnostics (TSXV: VPT) has entered into a new collaboration agreement as of this morning. The collaboration is with that
Read moreGeorge Adams, CEO of Ventripoint Diagnostics (TSXV: VPT) joins our host Cassandra Leah today to provide the inside scoop on
Read moreVentripoint Diagnostics (TSXV: VPT) has seen its technology installed at the largest cardiac centre in Canada. The company announced this
Read moreVentripoint Diagnostics (TSXV: VPT) this morning announced that it has installed its first VMS+3.0 whole-heart analysis system into a US
Read moreSometimes when it comes to the markets, the best thing that can happen to a company is being at the
Read more